Title Page -- Contents -- 1. Introduction -- 2. Open session -- 3. The new procedures for updating and disseminating the Model List -- 3.1 Background -- 3.2 Key features of the new procedures -- 3.3 Review of the new procedures -- 3.3.1 Applications for additions -- 3.3.2 Applications for deletions -- 3.3.3 Selection criteria -- 3.4 The WHO model formulary -- 3.5 The WHO Essential Medicines Library -- 4. Other outstanding technical issues -- 4.1 Change of name of the Expert Committee -- 4.2 Description of essential medicines -- 4.3 Role of treatment costs in relation to the Model List -- 4.4 Inclusion of additional items in the Model List -- 5. Format and presentation of the 12th Model List -- 5.1 Section headings -- 5.2 The core and complementary lists -- 5.3 The "square box" symbol -- 6. Changes made in revising the Model List -- 6.1 Applications for additions -- 6.1.1 Antiretroviral medicines -- 6.1.2 Artemether + lumefantrine (fixed-dose combination) -- 6.1.3 a /b -Arteether -- 6.1.4 Artemotil (b -arteether) -- 6.1.5 Amodiaquine -- 6.1.6 Insecticide-treated bednets -- 6.1.7 Miconazole nitrate buccal tablets -- 6.2 Applications for deletions -- 6.3 Other changes -- 6.3.1 Meglumine antimoniate -- 6.3.2 Antineoplastic and immunosuppressive medicines -- 6.3.3 Reserve list medicines -- 7. Future reviews of sections of the Model List -- 7.1 Update on the review of medicines for the treatment of hypertension -- 7.2 Review of the core and complementary lists -- 7.3 Review of the use of the "square box" symbol -- 7.4 Review of injectable medicines -- 7.5 Priorities for further systematic reviews -- 8. Recommendations -- 8.1 Procedures for updating and disseminating the Model List of Essential Medicines -- 8.2 Description of essential medicines -- 8.3 Presentation of the 12th Model List -- 8.4 Additions and changes to the Model List.

8.5 Deferred applications -- 8.6 Rejected applications -- 8.7 Priorities for future reviews of sections of the Model List -- 8.8 Change of name of the Expert Committee -- 8.9 Other recommendations -- Acknowledgements -- References -- Annex 1 The 12th WHO Model List of Essential Medicines -- Annex 2 Additional notes on the medicines recommended for inclusion in the 12th WHO Model List of Essential Medicines -- Annex 3 The Anatomical Therapeutic Chemical (ATC) classification system -- Alphabetical list of essential medicinces (with ATC classification codes).